SubHero Banner

LymePak (doxycycline hyclate) – New drug approval

June 15, 2018 - The FDA approved Chartwell Pharmaceuticals’ LymePak (doxycycline hyclate) tablets, for the treatment of early Lyme disease (as evidenced by erythema migrans) due to Borrelia burgdorferi in adults and pediatric patients 8 years of age and older weighing 45 kg and above.

Download PDF